ACM Research flags Q3 2026 revenue up to $365m, up 36% year-on-year
ACM Research has issued preliminary unaudited revenue guidance for the third quarter of 2026, putting expected sales in the range of $360 million to $365 million. That would represent year-on-year growth of between 34% and 36%, a solid acceleration for a capital equipment vendor operating in a market that has seen patchy demand recovery across different device segments.
The Fremont, California-based company also reported preliminary total shipments of $335 million to $340 million for the quarter, up 27% to 29% on the same period a year earlier. Shipments are a leading indicator of future recognised revenue, and the gap between the two figures suggests a modest backlog conversion in progress.
Full unaudited results, along with a revenue outlook for the remainder of 2026, are due on an earnings call scheduled for 5 November 2026. ACM has flagged that the preliminary figures remain subject to quarter-end closing procedures and review by its independent auditor.
Corporate structure and reporting complexity
A significant caveat accompanies the release. ACM Research holds a 73.2% equity stake in its principal operating subsidiary, ACM Research (Shanghai), which contributes the substantial majority of consolidated revenue and net income. ACM Shanghai reports under Chinese GAAP in renminbi and files separately with the Shanghai Stock Exchange. The two sets of numbers can diverge materially, and investors are advised to wait for the consolidated US GAAP figures before drawing firm conclusions on margins or net profit.
This dual-listed structure, with a US parent on NASDAQ and a majority-owned Shanghai subsidiary listed onshore in China, creates ongoing transparency complexity. Currency translation effects, intercompany eliminations, and differing accounting standards mean that headline revenue figures from each entity are not directly comparable.
Market context and competitive positioning
ACM Research competes in the semiconductor process equipment market against much larger incumbents including Applied Materials, Lam Research, and Tokyo Electron, as well as against regional Chinese suppliers that are expanding their domestic footprint. The company has carved out a position in wafer cleaning, electroplating, and advanced packaging tools, categories that are seeing sustained investment as chipmakers pursue heterogeneous integration and advanced packaging architectures to extend performance gains beyond traditional process node scaling.
The 34%-36% revenue growth rate, if confirmed, would significantly outpace the broader semiconductor equipment market, which has been recovering from a 2023-2024 inventory correction at a more modest pace. Strong growth at ACM is partly attributable to robust domestic Chinese semiconductor investment, as Chinese fabs accelerate equipment procurement in response to ongoing US export controls that restrict access to leading-edge tools from US and allied suppliers. That geopolitical tailwind carries its own risk: ACM Shanghai's customer concentration in the Chinese domestic market could become a liability if further restrictions target equipment categories in which ACM participates.
Regulatory backdrop
US Bureau of Industry and Security export control rules, tightened in 2023 and 2024, continue to reshape capital equipment flows into China. ACM Research's tools operate primarily in mature and semi-critical process steps rather than at the leading edge, which has so far kept the company outside the most restrictive licence requirements. However, the regulatory perimeter has been expanding, and any reclassification of ACM's cleaning or packaging tools could affect both its Chinese subsidiary's order book and the parent company's consolidated outlook. Investors and buyers will be watching the 5 November earnings call for any guidance on how management is navigating that exposure.